MedPath

Rotterdam Aphasia Therapy Study - 2.

Completed
Conditions
1. Experimental condition: CLT 0-6 m.p.oControl condition: no-CLT 0-6 m.p.o2. Experimental condition: CLT 0-3 m.p.o. followed by no-CLT 3-6 m.p.o.Control condition: no-CLT 0-3 m.p.o. followed by CLT 3-6 m.p.o.
Registration Number
NL-OMON25719
Brief Summary

Hagelstein, M. (in press). RATS-2: De effectiviteit van cognitief linguïstische therapie in de acute fase van afasie: een gerandomiseerde gecontroleerde trial. Afasiologie.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

1. Aphasia due to stroke;
2. Within 3 weeks post onset;
3. Age 18-85 years;
4. Language near native Dutch;
5. Life expectancy > 6 months.

Exclusion Criteria

1. Severe dysarthria;
2. Premorbid dementia;
3. Illiteracy;
4. Severe developmental dyslexia;
5. Severe visual perceptual disorders;
6.Existing aphasia;
7. Subarachnoidal haemorrhage;
8. Recent psychiatric disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The score at 6 months post onset on the Amsterdam Nijmegen Everyday Language Test (ANELT), scale A (Understandability).
Secondary Outcome Measures
NameTimeMethod
- Proportion of patients in each treatment group who improve at least 7 points on the ANELT<br>- A categorization of the ANELT into severe (score, 10-29) and moderate to mild (score, 30-48) communication deficits<br>- ScreeLing; Semantic Association Test (SAT), verbal version; Semantic Association words with low imageability, Nonwords Repetition and Auditory Lexical Decision (PALPA); semantic word fluency; letter fluency.
© Copyright 2025. All Rights Reserved by MedPath